MRKR Stock Analysis: Buy, Sell, or Hold?
MRKR - Marker Therapeutics, Inc. Common Stock
$1.25
0.03 (2.76%)
▲
5d:
+6.25%
30d:
-15.29%
90d:
-19.63%
HOLD
MODERATE Confidence
Analysis Updated: Aug 4, 2026 12:00 AM ET
Earnings: Aug 13, 2026
8d
Get Alerted When MRKR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: MRKR shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: MRKR shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: MRKR is currently trading at $1.25, which is considered slightly low relative to its 30-day fair value range of $1.20 to $1.50.
Technical Outlook: Technically, MRKR is in a downtrend. Immediate support is located at $1.05, while resistance sits at $1.32.
Market Sentiment: MRKR has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $7.87 (+596.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, MRKR is in a downtrend. Immediate support is located at $1.05, while resistance sits at $1.32.
Market Sentiment: MRKR has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $7.87 (+596.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$1.20 -
$1.50
Company Quality Score
41/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 596.2% below Wall St target ($7.87)
Trading Range Analysis
30-Day Trading Range
$1.20 -
$1.50
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$1.05
Resistance Level
$1.32
Current Trend
Downtrend
Technical data as of
Aug 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.50
Wall Street Target
$7.87
(+596.2%)
Revenue Growth (YoY)
-51.0%
Share & Embed Analysis
Last updated: August 04, 2026 2:06 PM ET
Data refreshes hourly during market hours. Next update: 3:06 PM
Data refreshes hourly during market hours. Next update: 3:06 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MRKR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$26 | 47 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1080 | 57 HOLD |
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 45 HOLD |
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$52 | 53 HOLD |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
20 analysts |
$127 | 56 HOLD |
